Meeder Asset Management Inc Athenex, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$11.06 - $14.01 $20,615 - $26,114	-1,864 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$10.26 - $14.55 $19,124 - $27,121	1,864 New	1,864 $22,000
Q2 2020 Aug 11, 2020	SELL	$7.11 - $13.76 $1,123 - $2,174	-158 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.71 - $15.85 $1,461 - $4,057	-256 Reduced 61.84%	158 $1,000
Q4 2019 Feb 13, 2020	SELL	$9.6 - $17.75 $2,102 - $3,887	-219 Reduced 34.6%	414 $6,000
Q3 2019 Oct 17, 2019	BUY	$12.16 - $21.0 $7,697 - $13,293	633 New	633 $8,000
Q4 2018 Jan 17, 2019	SELL	$10.24 - $15.49 $29,603 - $44,781	-2,891 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$15.53 - $19.97 $44,897 - $57,733	2,891 New	2,891 $0

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.